4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-22-053111
Options or other derivatives
- Director acquired 38,399 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Huang Andong Director | 2022-10-05 | Grant or award · Stock Option (Right to Buy) | +38,399 | 38,399 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…